Pharmaceutical major Cipla signs agreement with FIL Capital

Q.  Which pharmaceutical major has signed an investment agreement with FIL Capital Investments Mauritius II Ltd on 28th November 2015?
- Published on 30 Nov 15

a. Ranbaxy
b. Cipla
c. Sun
d. GlaxoSmithKline

ANSWER: Cipla
 
Pharma major Cipla Ltd, through its completely owned subsidiary Cipla Health and FIL Capital Investments (Mauritius) II Ltd have signed an agreement regarding the consumer healthcare business of Cipla, divested as a subsidiary in July in 2015. Investment is subject to approval from FIPB.

Related Content

➨ Post your comment / Share knowledge


Enter the code shown above:

(Note: If you cannot read the numbers in the above image, reload the page to generate a new one.)
▲